Pharmacologically inactive prodrugs that can be activated by near-infrared light are attractive candidates for clinical applications. Now, platinum-based photo-oxidants have been shown to eradicate tumours in mice with a new mode of action.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bevernaegie, R. et al. J. Am. Chem. Soc. 142, 2732–2737 (2020).
Cuello-Garibo, J.-A., Meijer, M. S. & Bonnet, S. Chem. Commun. 53, 6768–6771 (2017).
Steinke, S. J. et al. Chem. Sci. 13, 1933–1945 (2022).
McFarland, S. A., Mandel, A., Dumoulin-White, R. & Gasser, G. Curr. Opin. Chem. Biol. 56, 23–27 (2020).
Deng, Z. et al. Nat. Chem. https://doi.org/10.1038/s41557-023-01242-w (2023).
Johnstone, T. C., Suntharalingam, K. & Lippard, S. J. Chem. Rev. 116, 3436–3486 (2016).
Bolitho, E. M. et al. J. Am. Chem. Soc. 143, 20224–20240 (2021).
Roque, J. A. et al. Chem. Sci. 11, 9784–9806 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Vigueras, G., Gasser, G. Anticancer platinum-based photo-oxidants in a new light. Nat. Chem. 15, 896–898 (2023). https://doi.org/10.1038/s41557-023-01250-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41557-023-01250-w
